エディットフォース株式会社

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

Operating in deeptech based in Tokyo, Japan, エディットフォース株式会社 operates.

Profile

"EditForce is a deeptech company that leverages RNA editing technology developed at Kyushu University to pioneer new standards in various fields such as healthcare, industry, and agriculture. With a foundation in innovative RNA editing technology, EditForce aims to set new global standards by taking a unique approach different from traditional RNA editing techniques. In their drug development program, they utilize proprietary RNA editing technology to advance their pharmaceutical business. By developing a novel gene manipulation technology based on PPR proteins found in plants, EditForce is at the forefront of creating new genetic editing techniques. Their focus is on establishing treatment methods for various diseases in the pharmaceutical sector, with future plans to expand into creating new value in diverse fields such as chemical and agricultural industries."

Within the deeptech space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Tokyo, Japan.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: www.editforce.co.jp